Rosemary

NutraPedia - Evidence-Based Supplement Research

Back to Table of Contents
Health Goals: memory focus inflammation

Research Overview

Across the provided abstracts, rosemary (Rosmarinus officinalis L.) research is most developed in (i) phytochemistry and bioactive constituent identification (notably phenolic diterpenes such as carnosic acid and carnosol, and volatile components characterized by GC–MS), and (ii) preclinical evaluation of broad pharmacological activities—especially antioxidant, anti-inflammatory, and antimicrobial effects—often framed in the context of food preservation/natural additives and general “protective” health effects. Reviews synthesize extensive in vitro and in vivo findings suggesting rosemary-derived preparations (essential oil, extracts, hydrosol) can modulate oxidative stress and inflammatory pathways and inhibit microbial growth, aligning with its traditional culinary and preservative use. There is also targeted mechanistic work in specific domains, including an in vitro anticancer signal where carnosic acid reduced prostate cancer cell viability via effects on endoplasmic reticulum function.

The strongest evidence in this set supports rosemary as a source of bioactive compounds with measurable antioxidant/anti-inflammatory/antimicrobial activity in experimental systems, and it supports plausible mechanistic pathways for certain effects. For example, the insomnia-focused study combined network pharmacology, RNA-seq, molecular docking, and multiple behavioral/biochemical assays in a rat model to implicate serotonergic synapse signaling (e.g., HTR1A/5-HT1AR-related changes and downstream cAMP/PKA and GABAA markers) as a candidate mechanism for rosemary hydrosol’s effects; however, this remains animal evidence with acknowledged limits to human translation. Applied animal nutrition work (broilers under heat stress) indicates rosemary can be tested as a dietary additive affecting immune markers and, in combination with other botanicals, gut-related outcomes—though in the cited study oregano showed clearer performance and intestinal gene-expression benefits than rosemary alone.

Key gaps are consistent across the abstracts: more rigorous, human-relevant research is needed to establish clinical efficacy, dose–response relationships, safety, and standardized formulations for rosemary preparations (essential oil vs. extract vs. hydrosol), as well as to confirm mechanisms observed in vitro/animal models. The systematic review explicitly notes research gaps for several essential oils including rosemary, implying that evidence is uneven and often preclinical. Priority areas include well-designed randomized controlled trials for specific indications (e.g., sleep/affective symptoms, metabolic or inflammatory conditions), comparative studies across preparation types and active constituents (carnosic acid/carnosol vs. complex mixtures), and translational work linking molecular targets to clinically meaningful outcomes while accounting for bioavailability and potential adverse effects.

1. What conditions has Rosemary been studied for?

  • Insomnia (and related anxiety/depression features): Studied using rosemary hydrosol (aqueous distillate) in a rat insomnia model (PCPA-induced insomnia), with mechanistic work focused on serotonergic synapses and GABA-related signaling.

  • Metabolic syndrome / cardiometabolic risk factors: A review summarized rosemary and its phenolic compounds as being studied for hyperglycemia, dyslipidemia, inflammation, abdominal obesity, hypertension, and related atherosclerotic/thrombotic risk (primarily in vitro/in vivo evidence per the abstract).

  • Cancer (preclinical): A systematic review noted that carnosic acid (a key rosemary diterpene) can reduce prostate cancer cell viability via modifying endoplasmic reticulum function (cell-based evidence).

  • Anti-inflammatory, antioxidant, antimicrobial applications: Multiple reviews included rosemary among essential oils/spices with these properties; these are often studied in vitro and in animal models, and also in food preservation contexts.

  • Topical/skin use (general): One abstract notes topical administration as an important route to avoid systemic absorption; the provided snippet does not specify a rosemary-specific skin condition, but indicates topical delivery is a relevant context.

  • Food preservation / food quality protection (non-medical outcomes): Rosemary extract used in glazing frozen shrimp to reduce protein degradation and lipid oxidation during long-term frozen storage.

  • Livestock production under stress (non-human): Rosemary added to broiler diets under heat stress (HS) as part of a study on growth inhibition, digestive enzymes, microbiome-related outcomes, immune markers, and antioxidant/tight junction gene expression (effects were more clearly attributed to oregano in the abstract).

2. Does it work in treating those conditions? Summarize the evidence.

  • Insomnia: In a rat model, rosemary hydrosol produced dose-related improvements across behavioral testing (open field) and biomarkers (ELISA for 5-HT, GABA, DA; plus Western blot, RT-PCR, immunohistochemistry). The authors identified serotonergic synapse signaling as a key pathway and proposed synergy among several volatile components (e.g., caryophyllene acting via HTR1A/5-HT1A-related signaling and downstream cAMP/PKA and GABAA changes). Limitation: the abstract explicitly notes this was in rats and may not apply to humans.

  • Metabolic syndrome: The evidence in the provided material is review-level and described as being documented in in vitro and in vivo studies, with claimed effects including hypoglycemic, hypolipidemic, hypotensive, and anti-atherosclerotic actions. Limitation: the abstract does not describe specific human randomized trial outcomes for rosemary itself (it summarizes mechanistic and preclinical literature).

  • Prostate cancer (cell-based): A systematic review states that carnosic acid in rosemary oil can reduce prostate cancer cell viability by modifying endoplasmic reticulum function. Limitation: this is preclinical (cell viability), not clinical cancer treatment evidence.

  • Antimicrobial/antioxidant/anti-inflammatory effects: Reviews conclude essential oils (including rosemary) show these activities and propose mechanisms; however, the rosemary-specific human clinical evidence is not detailed in the provided abstracts, and one review explicitly calls for more research for oils including rosemary.

  • Food quality preservation: In frozen shrimp, glazing with rosemary extract was more effective than water glazing at reducing quality loss (lower TVB-N, drip loss, peroxide value, free fatty acids; higher lipid content and sensory scores) over 24 weeks at -20°C. This supports efficacy for food preservation, not treatment of human disease.

  • Broilers under heat stress: The study included rosemary arms (50 and 100 mg/kg), but the abstract’s main positive findings were driven by oregano extract (not rosemary), especially at 50 mg/kg. Rosemary and oregano together reduced IgG and IgM, but the abstract does not clearly attribute growth or gut integrity benefits to rosemary alone.

3. What health benefits does it have?

  • Neurobehavioral/sleep-related potential (preclinical): Rosemary hydrosol improved insomnia-like outcomes in rats, with proposed modulation of serotonergic synapse signaling and GABA-related pathways.

  • Cardiometabolic risk modulation (mostly preclinical per abstract): A metabolic syndrome-focused review describes rosemary as a source of phenolic phytochemicals with reported anti-oxidant and anti-inflammatory effects and potential hypoglycemic, hypolipidemic, hypotensive, anti-atherosclerotic, anti-thrombotic, hepatoprotective, and hypocholesterolemic actions (noted as documented in in vitro/in vivo studies).

  • Antioxidant and anti-inflammatory activity: Multiple reviews of spices/essential oils describe rosemary as an “excellent source of antioxidants” due to high phenolic content and list anti-inflammatory activity among commonly reported properties.

  • Antimicrobial activity: Included among essential oils with antimicrobial effects in systematic review coverage (though rosemary-specific clinical outcomes are not provided in the abstracts).

  • Antiproliferative/antitumor potential (preclinical): Reviews describe antiproliferative/antitumor activities; one specific example given is carnosic acid reducing prostate cancer cell viability (cell-based evidence).

4. Does it have any downsides or side effects?

  • Allergic reactions/dermatitis: A toxicity review notes rosemary is generally considered safe for consumption and topical application, but allergic reactions and dermatitis have been reported in some individuals.

  • Potential organ toxicity at chronic/high doses (evidence summarized in a toxicity review): Reported toxicological findings include effects on liver and kidney (e.g., atrophic/degenerative changes; increased BUN and AST; reduced total serum protein levels).

  • Potential reproductive toxicity (reviewed evidence): The toxicity review describes findings such as decreased spermatogenesis, testosterone, sperm density, and motility.

  • Potential genotoxicity/teratology signals (reviewed evidence): The toxicity review mentions mechanisms consistent with genotoxicity and fetal anomalies (e.g., DNA fragmentation and apoptotic changes) and advises caution, particularly with chronic/high doses.

  • Drug interaction caution: The toxicity review underscores the importance of considering drug interactions, though specific interacting drugs are not listed in the provided abstract.

  • Evidence limitations: Many benefits described are based on in vitro/animal studies and reviews; the toxicity review emphasizes the need to interpret toxicology in realistic exposure situations and calls for further research.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

The provided abstracts do not report pharmacogenomic findings for rosemary (e.g., effects modified by human genetic variants in drug-metabolizing enzymes/transporters or receptor polymorphisms).

  • No direct variant-specific evidence: None of the abstracts identify specific genotypes (such as CYP450 variants, serotonin receptor polymorphisms, etc.) that predict benefit or harm from rosemary.

  • Mechanistic hints are not pharmacogenomics: The insomnia rat study implicates targets/pathways (e.g., HTR1A/5-HT1A-related signaling, GABAA-related changes), but it does not evaluate genetic variation, and it is not in humans.

  • Practical implication: Based on these abstracts alone, no evidence-based recommendations can be made to tailor rosemary use according to genetic variants.

References

  1. Essential oils: a systematic review on revolutionizing health, nutrition, and omics for optimal well-being.
    Camila Pezantes-Orellana, Fátima German Bermúdez, Carmen Matías De la Cruz, José Luis Montalvo, Andrea Orellana-Manzano (2024) - Frontiers in medicine
  2. Anti-Inflammatory Therapeutic Mechanisms of Natural Products: Insight from Rosemary Diterpenes, Carnosic Acid and Carnosol.
    Solomon Habtemariam (2023) - Biomedicines
  3. Antioxidant and Antimicrobial Properties of Rosemary (
    Gema Nieto, Gaspar Ros, Julián Castillo (2018) - Medicines (Basel, Switzerland)
  4. Rosmarinus officinalis L. (rosemary) as therapeutic and prophylactic agent.
    Jonatas Rafael de Oliveira, Samira Esteves Afonso Camargo, Luciane Dias de Oliveira (2019) - Journal of biomedical science
  5. Therapeutic effects of rosemary (
    Mahboobeh Ghasemzadeh Rahbardar, Hossein Hosseinzadeh (2020) - Iranian journal of basic medical sciences
  6. Rosemary (
    Lucas Malvezzi de Macedo, Érica Mendes Dos Santos, Lucas Militão, Louise Lacalendola Tundisi, Janaína Artem Ataide, Eliana Barbosa Souto, Priscila Gava Mazzola (2020) - Plants (Basel, Switzerland)
  7. Potential Therapeutic Use of the Rosemary Diterpene Carnosic Acid for Alzheimer's Disease, Parkinson's Disease, and Long-COVID through NRF2 Activation to Counteract the NLRP3 Inflammasome.
    Takumi Satoh, Dorit Trudler, Chang-Ki Oh, Stuart A Lipton (2022) - Antioxidants (Basel, Switzerland)
  8. Health Benefits of Culinary Herbs and Spices.
    T Alan Jiang (2019) - Journal of AOAC International
  9. Rosemary (Rosmarinus officinalis L.) hydrosol based on serotonergic synapse for insomnia.
    Taotao Li, Wenfei Wang, Qiuting Guo, Jia Li, Tiantian Tang, Yujiao Wang, Ding Liu, Kai Yang, Jiayi Li, Kaixue Deng, Fang Wang, Huiting Li, Zhenfeng Wu, Jianbo Guo, Dongyan Guo, Yajun Shi, Junbo Zou, Jing Sun, Xiaofei Zhang, Ming Yang (2024) - Journal of ethnopharmacology
  10. Effects of oregano and/or rosemary extracts on growth performance, digestive enzyme activities, cecal bacteria, tight junction proteins, and antioxidants-related genes in heat-stressed broiler chickens.
    Mahmoud Madkour, Mohamad M Aboelenin, Walid S Habashy, Ibrahim A Matter, Mohamed Shourrap, Mona A Hemida, Ahmed A Elolimy, Osama Aboelazab (2024) - Poultry science
  11. Effect of glazing and rosemary (Rosmarinus officinalis) extract on preservation of mud shrimp (Solenocera melantho) during frozen storage.
    Jing Shi, Yutian Lei, Huixing Shen, Hui Hong, Xunpei Yu, Beiwei Zhu, Yongkang Luo (2019) - Food chemistry
  12. Rosemary (Rosmarinus officinalis) as a potential therapeutic plant in metabolic syndrome: a review.
    Faezeh Vahdati Hassani, Kobra Shirani, Hossein Hosseinzadeh (2016) - Naunyn-Schmiedeberg's archives of pharmacology
  13. Toxicity and safety of rosemary (Rosmarinus officinalis): a comprehensive review.
    Mahboobeh Ghasemzadeh Rahbardar, Hossein Hosseinzadeh (2025) - Naunyn-Schmiedeberg's archives of pharmacology
  14. Anticancer Activity of
    Alessandro Allegra, Alessandro Tonacci, Giovanni Pioggia, Caterina Musolino, Sebastiano Gangemi (2020) - Nutrients
  15. The Therapeutic Potential of Rosemary (Rosmarinus officinalis) Diterpenes for Alzheimer's Disease.
    Solomon Habtemariam (2016) - Evidence-based complementary and alternative medicine : eCAM
  16. Rosemary and neem: an insight into their combined anti-dandruff and anti-hair loss efficacy.
    Mona M Hashem, Dalia Attia, Yomna A Hashem, Moataz S Hendy, Safa AbdelBasset, Farah Adel, Maha M Salama (2024) - Scientific reports
  17. Antioxidant activity and protecting health effects of common medicinal plants.
    Soňa Škrovánková, Ladislava Mišurcová, Ludmila Machů (2012) - Advances in food and nutrition research
  18. An updated review of protective effects of rosemary and its active constituents against natural and chemical toxicities.
    Mohaddeseh Sadat Alavi, Sahar Fanoudi, Mahboobeh Ghasemzadeh Rahbardar, Soghra Mehri, Hossein Hosseinzadeh (2021) - Phytotherapy research : PTR
  19. Rosemary Extract as a Potential Anti-Hyperglycemic Agent: Current Evidence and Future Perspectives.
    Madina Naimi, Filip Vlavcheski, Hesham Shamshoum, Evangelia Tsiani (2017) - Nutrients
  20. Diterpenes from rosemary (Rosmarinus officinalis): Defining their potential for anti-cancer activity.
    Sakina M Petiwala, Jeremy J Johnson (2015) - Cancer letters


Want personalized supplement recommendations based on your genetics?
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!